M 125 (Glyburide (micronized) 3 mg)
Pill imprint M 125 has been identified as Glyburide (micronized) 3 mg.
Glyburide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glyburide 3 mg is not a controlled substance under the Controlled Substance Act (CSA).
Glyburide (micronized)
- Imprint:
- M 125
- Strength:
- 3 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-1125
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
croscarmellose sodium
magnesium stearate
corn starch
sodium lauryl sulfate
D&C Yellow No. 10
| NDC Code | Manufacturer / Repackager |
|---|---|
| 43063-0119 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More about glyburide
Consumer resources
- Other brands: DiaBeta, Micronase, Glynase, Glycron, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
